Ketamine Infusions for RSD: Benefits, Limits, and Safety

Reflex Sympathetic Dystrophy, now more commonly called Complex Regional Pain Syndrome (CRPS), can cause burning pain, unusual sensitivity, swelling, temperature or colour changes, stiffness, and reduced movement. The condition may develop after an injury, surgery, fracture, or nerve irritation, although the original trigger is not always clear.

Ketamine infusions have attracted attention because they act on pain-processing pathways that may become overactive in CRPS. They are sometimes considered when standard treatments have provided insufficient relief, but they are not a guaranteed cure and require careful assessment by an experienced pain team.

Understanding RSD and Ketamine

CRPS involves changes in the peripheral and central nervous systems. Signals from the affected limb can become amplified, while inflammation, altered blood flow, muscle guarding, and fear of movement may reinforce the pain cycle. This can make ordinary touch, clothing, or temperature changes feel intensely painful.

Ketamine is an anaesthetic medicine that, at lower doses, can be used for pain management. It blocks N-methyl-D-aspartate (NMDA) receptors, which are involved in glutamate signalling and central sensitisation. By reducing excessive activity in these pathways, ketamine may temporarily lower pain intensity and make movement or rehabilitation more achievable.

The medicine does not repair damaged tissue or reverse every change associated with CRPS. Its potential value is usually measured by improved function, sleep, participation in physiotherapy, and quality of life, rather than pain reduction alone.

How Infusions May Reduce Pain

A typical pain-management infusion delivers ketamine slowly through an intravenous line, with the dose adjusted according to body weight, response, and side effects. Some clinics use a short session, while others provide treatment over several hours or a series of appointments. Protocols vary because there is no single internationally accepted regimen for CRPS.

Patients may experience reduced pain during or shortly after the infusion, although the duration of benefit differs widely. Some people report relief lasting days or weeks, while others experience little change. A response may allow a person to begin graded movement, desensitisation, occupational therapy, or other rehabilitation that was previously too difficult.

Ketamine should be viewed as one part of a broader plan. Psychological support, sleep management, physical rehabilitation, medicines for nerve pain, and strategies for maintaining normal activity can all influence the outcome. Abruptly pushing an affected limb after pain drops may increase flare-ups, so progression should remain gradual.

What the Evidence Shows

Research into ketamine for CRPS includes small clinical trials, observational studies, and reviews with differing methods. Some studies suggest meaningful short-term pain relief, particularly in people with recent or treatment-resistant symptoms. Evidence for long-term benefit is less consistent, and repeated infusions have not been studied well enough to establish a universally reliable maintenance schedule.

Results can also be difficult to compare because studies use different doses, infusion durations, outcome measures, and follow-up periods. A lower pain score does not always translate into better walking, work capacity, mood, or independence. An honest discussion should cover the possibility of a partial response, no response, or relief that fades.

In Australia, a specialist may recommend ketamine outside its formally approved indications, known as off-label use. That does not automatically mean the treatment is inappropriate, but it makes informed consent and specialist oversight particularly important. Patients can also discuss other emerging options, including scrambler therapy, where available.

How Treatment Is Delivered In Australia

Assessment commonly begins with a general practitioner, neurologist, rehabilitation physician, or specialist pain service. Public multidisciplinary clinics exist in major centres such as Sydney, Melbourne, Brisbane, Perth, and Adelaide, although waiting times and eligibility criteria vary. Private pain clinics may offer consultations and infusions sooner, but fees, follow-up arrangements, and medication protocols differ between providers.

Ketamine treatment is not routinely funded through the Pharmaceutical Benefits Scheme as a standard CRPS infusion program. Medicare coverage may apply to some consultations or hospital services, depending on the setting and referral pathway, while the infusion itself may involve out-of-pocket costs. Ask for a written estimate that separates the specialist fee, facility charge, monitoring, medicines, and review appointments.

Australian clinics should explain who will administer the medicine, what monitoring is used, how emergencies are handled, and whether a responsible adult must take the patient home. Driving is generally unsafe after treatment, and many services recommend avoiding important decisions, alcohol, and operating machinery until the following day or as advised.

Risks, Side Effects, and Safety

During an infusion, possible effects include dizziness, nausea, blurred vision, drowsiness, increased blood pressure, faster heart rate, altered hearing, vivid dreams, or a feeling of detachment from the surroundings. These effects are more likely when the dose rises quickly. Continuous observation and appropriate equipment help staff respond if a reaction occurs.

Repeated or high-dose exposure may carry additional concerns, including urinary or bladder problems, liver abnormalities, tolerance, dependence, and changes in mood or cognition. Ketamine may be unsuitable for some people with uncontrolled hypertension, serious cardiovascular disease, certain psychotic illnesses, significant liver disease, or a history of problematic substance use. The treating clinician should review all medicines, including opioids, sedatives, antidepressants, and recreational drugs.

Seek urgent medical help for severe chest symptoms, fainting, extreme confusion, difficulty breathing, severe agitation, or an allergic reaction. New urinary pain, blood in the urine, yellowing of the skin, or persistent vomiting after repeated treatment also warrants prompt medical review.

Making A Careful Treatment Decision

Before agreeing to an infusion, clarify the treatment goal and how improvement will be measured. Useful outcomes may include walking distance, hand use, sleep, attendance at work, reduced reliance on rescue medicines, or greater tolerance of physiotherapy. A written plan should state when treatment will stop if there is no meaningful benefit and how progress will be reviewed.

The broader effects of CRPS can reach employment, finances, relationships, and mental health. People managing symptoms at work may find practical guidance in talking to an employer, especially when discussing pacing, flexible duties, breaks, or workplace adjustments. Support from family, a psychologist, or a pain-management group can complement medical care.

Keep a record of pain, movement, sleep, side effects, and daily function before and after treatment. Share it with the specialist rather than judging success by a single difficult day. A balanced decision weighs possible short-term relief against cost, inconvenience, medical risks, and the availability of rehabilitation support.

Discuss ketamine infusions with a qualified Australian pain specialist who can review the diagnosis, medical history, current medicines, and treatment alternatives. Use the appointment to request clear information about expected benefits, monitoring, fees, follow-up, and a plan for continuing rehabilitation safely.